XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 105,444 $ 143,612
Accounts receivable, net of allowance for credit losses of $12,059 and $9,878, respectively 37,019 43,121
Inventories 73,469 62,600
Other current assets and prepaid expenses 19,294 19,852
Total current assets 235,226 269,185
Long-term inventories 20,582 16,283
Property and equipment, net 31,964 37,275
Deferred tax assets 534 579
Goodwill 1,339 1,339
Operating lease right-of-use assets 12,034 10,055
Other long-term assets 10,313 11,575
Total assets 311,992 346,291
Current liabilities:    
Accounts payable 13,316 19,829
Accrued liabilities 47,119 55,055
Operating lease liabilities 3,231 2,441
Deferred revenue 9,038 10,422
Total current liabilities 72,704 87,747
Deferred revenue, net of current portion 1,417 1,494
Operating lease liabilities, net of current portion 10,046 8,887
Convertible notes, net of unamortized debt issuance costs of $9,859 and $10,430, respectively 419,266 418,695
Other long-term liabilities 1,122 1,298
Total liabilities 504,555 518,121
Commitments and contingencies
Stockholders’ deficit:    
Common stock, $0.001 par value; authorized: 50,000,000 shares; issued and outstanding: 20,067,941 and 19,960,622 shares at March 31, 2024 and December 31, 2023, respectively 20 20
Additional paid-in capital 133,541 131,496
Accumulated deficit (326,124) (303,346)
Total stockholders’ deficit (192,563) (171,830)
Total liabilities and stockholders’ deficit $ 311,992 $ 346,291